脑转移瘤的临床试验
总计31866个结果
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, France终止
-
OHSU Knight Cancer InstituteMerck Sharp & Dohme LLC; Oregon Health and Science University终止
-
Guangdong Association of Clinical Trials尚未招聘
-
Shandong Cancer Hospital and InstituteAstraZeneca未知非小细胞肺癌 | 脑转移 | EGFR-TKI 耐药突变 | AZD9291
-
Xiangya Hospital of Central South UniversityWu Jieping Medical Foundation招聘中
-
Jeffrey ClarkeGenentech, Inc.; Duke University终止
-
Shanghai Chest Hospital未知
-
Ryan Gentzler, MDMirati Therapeutics Inc.; University of Virginia招聘中
-
Institut Curie未知
-
Sklifosovsky Institute of Emergency Care招聘中
-
Ohio State University Comprehensive Cancer CenterBristol-Myers Squibb完全的
-
Northwestern UniversityNational Cancer Institute (NCI)撤销脑和中枢神经系统肿瘤 | 未明确的成人实体瘤,特定方案 | 发作
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Medical University of ViennaDaiichi Sankyo, Inc.完全的
-
Shandong Cancer Hospital and Institute未知
-
Second Affiliated Hospital of Nanchang UniversityFujian Cancer Hospital; Hunan Cancer Hospital尚未招聘非小细胞肺癌 | 脑转移
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)招聘中
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Wake Forest University Health SciencesSpectrum Pharmaceuticals, Inc撤销
-
BBB-Therapeutics B.V.完全的
-
Zhejiang Cancer Hospital未知
-
Instituto Nacional de Cancerologia de Mexico招聘中
-
First People's Hospital of Hangzhou尚未招聘
-
Sun Yat-sen UniversityWu Jieping Medical Foundation招聘中
-
Sun Yat-sen University尚未招聘
-
British Columbia Cancer AgencySunnybrook Health Sciences Centre; AstraZeneca; Princess Margaret Hospital, Canada招聘中
-
Instituto Nacional de Cancerologia de Mexico完全的II期临床试验 | 96 例经组织学证实的 BM NSCLC 患者 | 随机 1:1 接受 TN 加 WBR 或仅接受 WBR | ICPFS 由两位盲法独立放射肿瘤学家通过 MRI 评估墨西哥